Literature DB >> 21412950

Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1.

Fernando Cardona1, Jose Vicente Sánchez-Mut, Hernán Dopazo, Jordi Pérez-Tur.   

Abstract

Parkinson disease (PD) is the second most common neurodegenerative disorder and is characterized by the loss of dopaminergic neurons in the substantia nigra. Mutations in PINK1 were shown to cause recessive familial PD, and today are proposed to be associated with the disease via mitochondrial dysfunction and oxidative damage. The PINK1 gene comprises eight exons, which encode a ubiquitously expressed 581 amino acid protein that contains an N-terminal mitochondrial targeting domain and a serine/threonine protein kinase. To better understand the relationship between PINK1 and PD we have first analyzed the evolutionary history of the gene showing its late emergence in evolution. In addition, we have modeled the three-dimensional structure of PINK1 and found some evidences that help to explain the effect of some PD-related mutations in this protein's function.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412950     DOI: 10.1002/humu.21444

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.

Authors:  Nicholas T Hertz; Amandine Berthet; Martin L Sos; Kurt S Thorn; Al L Burlingame; Ken Nakamura; Kevan M Shokat
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

2.  Structural and functional in silico analysis of LRRK2 missense substitutions.

Authors:  Fernando Cardona; Marta Tormos-Pérez; Jordi Pérez-Tur
Journal:  Mol Biol Rep       Date:  2014-02-02       Impact factor: 2.316

Review 3.  Mechanisms of PINK1, ubiquitin and Parkin interactions in mitochondrial quality control and beyond.

Authors:  Andrew N Bayne; Jean-François Trempe
Journal:  Cell Mol Life Sci       Date:  2019-06-28       Impact factor: 9.261

4.  PINK1: Multiple mechanisms of neuroprotection.

Authors:  Britney N Lizama; P Anthony Otero; Charleen T Chu
Journal:  Int Rev Mov Disord       Date:  2021-10-04

5.  Pink1 promotes cell proliferation and affects glycolysis in breast cancer.

Authors:  Jing Li; Xuting Xu; Huilian Huang; Liqin Li; Jing Chen; Yunfeng Ding; Jinliang Ping
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-11

6.  Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila.

Authors:  Saera Song; Seoyeon Jang; Jeehye Park; Sunhoe Bang; Sekyu Choi; Kyum-Yil Kwon; Xiaoxi Zhuang; Eunjoon Kim; Jongkyeong Chung
Journal:  J Biol Chem       Date:  2013-01-09       Impact factor: 5.157

7.  PINK1 autophosphorylation is required for ubiquitin recognition.

Authors:  Shafqat Rasool; Naoto Soya; Luc Truong; Nathalie Croteau; Gergely L Lukacs; Jean-François Trempe
Journal:  EMBO Rep       Date:  2018-02-23       Impact factor: 8.807

8.  Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection.

Authors:  Jean-François Trempe; Edward A Fon
Journal:  Front Neurol       Date:  2013-04-19       Impact factor: 4.003

9.  Mitochondrial Ca2+ oscillation induces mitophagy initiation through the PINK1-Parkin pathway.

Authors:  Zhengying Yu; Haipeng Wang; Wanyi Tang; Shaoyang Wang; Xiaoying Tian; Yujie Zhu; Hao He
Journal:  Cell Death Dis       Date:  2021-06-19       Impact factor: 8.469

10.  PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria.

Authors:  Kei Okatsu; Toshihiko Oka; Masahiro Iguchi; Kenji Imamura; Hidetaka Kosako; Naoki Tani; Mayumi Kimura; Etsu Go; Fumika Koyano; Manabu Funayama; Kahori Shiba-Fukushima; Shigeto Sato; Hideaki Shimizu; Yuko Fukunaga; Hisaaki Taniguchi; Masaaki Komatsu; Nobutaka Hattori; Katsuyoshi Mihara; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.